好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Laquinimod modulates central nervous system inflammation via the aryl hydrocarbon receptor and is effective in the chronic NOD progressive EAE model
Multiple Sclerosis
P2 - (-)
353
Authors/Disclosures

PRESENTER
No disclosure on file
No disclosure on file
No disclosure on file
Veit Rothhammer, MD (Universität Erlangen-Nuernberg) Prof. Rothhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Rothhammer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Prof. Rothhammer has received research support from German Research Foundation. The institution of Prof. Rothhammer has received research support from European Research Council.
Francisco J. Quintana, PhD (Brigham and Women's Hospital/Harvard Medical) Dr. Quintana has nothing to disclose.